Frans Van de Werf

Active 1984–2024

213
Papers
72,372
Citations
121
h-index
208
i10-index

Citations

Citations per year for Frans Van de Werf1947: 1 citations1984: 12 citations1985: 29 citations1986: 30 citations1987: 42 citations1988: 46 citations1989: 42 citations1990: 29 citations1991: 29 citations1992: 35 citations1993: 47 citations1994: 40 citations1995: 50 citations1996: 79 citations1997: 75 citations1998: 109 citations1999: 119 citations2000: 190 citations2001: 212 citations2002: 169 citations2003: 252 citations2004: 296 citations2005: 292 citations2006: 316 citations2007: 425 citations2008: 375 citations2009: 375 citations2010: 402 citations2011: 411 citations2012: 416 citations2013: 414 citations2014: 470 citations2015: 469 citations2016: 413 citations2017: 459 citations2018: 364 citations2019: 1,579 citations2020: 1,747 citations2021: 1,412 citations2022: 931 citations2023: 680 citations2024: 1,125 citations2025: 426 citations2026: 13 citations1948–1983: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,878 citing papers, 19.9% of this breakdownUnited Kingdom: 2,043 citing papers, 8.3% of this breakdownGermany: 1,490 citing papers, 6.1% of this breakdownChina: 1,480 citing papers, 6% of this breakdownItaly: 1,457 citing papers, 5.9% of this breakdownCanada: 1,099 citing papers, 4.5% of this breakdownNetherlands: 1,001 citing papers, 4.1% of this breakdownFrance: 972 citing papers, 4% of this breakdownSpain: 775 citing papers, 3.2% of this breakdownAustralia: 666 citing papers, 2.7% of this breakdownSwitzerland: 624 citing papers, 2.5% of this breakdownJapan: 612 citing papers, 2.5% of this breakdown
0%19.9%Other 30.3%

Fields

  • Medicine83.9%
  • Biochemistry, Genetics and Molecular Biology7.9%
  • Engineering2.1%
  • Immunology and Microbiology1.7%
  • Computer Science0.8%
  • Economics, Econometrics and Finance0.6%
  • Other3%

Topics

  • Acute Myocardial Infarction Research9.8%
  • Cardiac Imaging and Diagnostics5.1%
  • Coronary Interventions and Diagnostics4.6%
  • Antiplatelet Therapy and Cardiovascular Diseases4.1%
  • Atrial Fibrillation Management and Outcomes2.7%
  • Cardiovascular Function and Risk Factors2.5%
  • Other71.2%

Coauthors

All papers

Open in search
  1. Fourth universal definition of myocardial infarction (2018)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , P J Devereaux, Jose Luis Zamorano, Bertil Lindahl, William S Weintraub, L Kristin Newby, Renu Virmani, Pascal Vranckx, Don Cutlip, Raymond J Gibbons, Sidney C Smith, Dan Atar, Russell V Luepker, Rose Marie Robertson, Robert O Bonow, P Gabriel Steg, Patrick T O’Gara, Keith A A Fox, David Hasdai, Victor Aboyans, Stephan Achenbach, Stefan Agewall, Thomas Alexander, Alvaro Avezum, Emanuele Barbato, Jean-Pierre Bassand, Eric Bates, John A Bittl, Güenter Breithardt, Héctor Bueno, Raffaele Bugiardini, Mauricio G Cohen, George Dangas, James A de Lemos, Victoria Delgado, Gerasimos Filippatos, Edward Fry, Christopher B Granger, Sigrun Halvorsen, Mark A Hlatky, Borja Ibanez, Stefan James, Adnan Kastrati, Christophe Leclercq, Kenneth W Mahaffey, Laxmi Mehta, Christian Müller, Carlo Patrono, Massimo Francesco Piepoli, Daniel Piñeiro, Marco Roffi, Andrea Rubboli, Samin Sharma, Iain A Simpson, Michael Tendera, Marco Valgimigli, Allard C van der Wal, Stephan Windecker, Mohamed Chettibi, Hamlet Hayrapetyan, Franz Xaver Roithinger, Farid Aliyev, Volha Sujayeva, Marc J Claeys, Elnur Smajić, Petr Kala, Kasper Karmak Iversen, Ehab El Hefny, Toomas Marandi, Pekka Porela, Slobodan Antov and 29 more - European Heart Journal 2018 cited by 5,819

  2. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Victora Delgado, Donna Fitzsimons, Oliver Gaemperli, Nazzareno Galiè, Martine Gilard, Christian W. Hamm, Borja Ibáñez, Bernard Iung, Stefan James, Juhani Knuuti, Ulf Landmesser, Christophe Leclercq, Maddalena Lettino, Gregory Y.H. Lip, Massimo Francesco Piepoli, Luc Piérard, Markus Schwerzmann, Udo Sechtem, Iain A Simpson, Miguel Sousa‐Uva, Eugenio Stabile, Robert F. Storey, Michał Tendera, Frans Van de Werf, Freek W.A. Verheugt, Victor Aboyans, Stephan Windecker, Victor Aboyans, Stefan Agewall, Emanuele Barbato, Héctor Bueno, António Coca, Jean‐Philippe Collet, Ioan Mircea Coman, Verónica Dean, Victoria Delgado, Donna Fitzsimons, Oliver Gaemperli, Gerhard Hindricks, Bernard Iung, Peter Jüni, Hugo A. Katus, Juhani Knuuti, Patrizio Lancellotti, Christophe Leclercq, Theresa A. McDonagh, Massimo Piepoli, Piotr Ponikowski, Dimitrios Richter, Marco Roffi, Е. V. Shlyakhto, Iain A Simpson, Jose Luis Zamorano, Stephan Windecker, Victor Aboyans, Stefan Agewall, Emanuele Barbato, Héctor Bueno, António Coca, Jean‐Philippe Collet, Ioan Mircea Coman, Verónica Dean, Victoria Delgado, Donna Fitzsimons, Oliver Gaemperli, Gerhard Hindricks, Bernard Iung, Peter Jüni, Hugo A. Katus, Juhani Knuuti and 54 more - European Heart Journal 2017 cited by 2,979

  3. Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes

    Authors: , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2015 cited by 2,590

  4. Evolving Therapies for Myocardial Ischemia/Reperfusion Injury

    Authors: , , , - Journal of the American College of Cardiology 2015 cited by 992

  5. openalex_id:w2145813488

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Monika Stoll, Klaus Berger, Nicola Martinelli, Domenico Girelli, Pascal McKeown, Christopher Patterson, Stephen E. Epstein, Joseph M. Devaney, Mary-Susan Burnett, Vincent Mooser, Samuli Ripatti, Ida Surakka, Markku S. Nieminen, Juha Sinisalo, Marja‐Liisa Lokki, Markus Perola, Aki S. Havulinna, Ulf dé Fairé, Bruna Gigante, Erik Ingelsson, Tanja Zeller, Philipp S. Wild, Paul I. W. de Bakker, Olaf H. Klungel, Anke H. Maitland‐van der Zee, Bas Peters, Anthonius de Boer, Diederick E. Grobbee, Pieter W. Kamphuisen, Vera H.M. Deneer, Clara C. Elbers, N. Charlotte Onland‐Moret, Marten H. Hofker, Cisca Wijmenga, W. M. Monique Verschuren, Jolanda M.A. Boer, Yvonne T. van der Schouw, Asif Rasheed, Philippe Frossard, Serkalem Demissie, Cristen J. Willer, Ron Do, José M. Ordovás, Gonçalo R. Abecasis, Michael Boehnke, Karen L. Mohlke, Mark J. Daly, Candace Guiducci, Noël P. Burtt, Aarti Surti, Elena González, Shaun Purcell, Stacey Gabriel, Jaume Marrugat, John F. Peden, Jeanette Erdmann, Patrick Diemert, Christina Willenborg, Inke R. König, Marcus Fischer, Christian Hengstenberg, Andreas Ziegler, Ian Buysschaert, Diether Lambrechts, Frans Van de Werf, Keith A.A. Fox, Nour Eddine El Mokhtari, Deborah C. Rubin, Jürgen Schrezenmeir, Stefan Schreiber and 26 more cited by 2,293

  6. Polypill Strategy in Secondary Cardiovascular Prevention

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Timothy Collier, Frans Van de Werf, Pablo Perel, Moisés Rodríguez‐Mañero, Ángeles García, Marco Proietti, Mikkel Malby Schoos, Tabassome Simon, José Fernández‐Ferro, Nicolás López, Ettore Beghi, Yannick Béjot, David Vivas, Alberto Cordero, Borja Ibáñez, Valentı́n Fuster - New England Journal of Medicine 2022 cited by 316

  7. Dabigatran versus Warfarin in Patients with Mechanical Heart Valves

    Authors: , , , , , , , , , , , , , , , , - New England Journal of Medicine 2013 cited by 1,496

  8. Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both

    Authors: , , , , , , , , , , , , , , , - New England Journal of Medicine 2003 cited by 2,489

  9. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE)

    Authors: , , , , , , , , , , - BMJ 2006 cited by 1,652

  10. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christian Funck-Brentano, David Hasdai, Arno Hoes, Paulus Kirchhof, Juhani Knuuti, Philippe Kolh, Theresa McDonagh, Cyril Moulin, Bogdan A. Popescu, Željko Reiner, Udo Sechtem, Per Anton Sirnes, Michal Tendera, Adam Torbicki, Alec Vahanian, Stephan Windecker, Document Reviewers, David Hasdai, Felicity Astin, Karin Åström-Olsson, Andrzej Budaj, Peter Clemmensen, Jean-Philippe Collet, Keith A. Fox, Ahmet Fuat, Olivija Gustiene, Christian W. Hamm, Petr Kala, Patrizio Lancellotti, Aldo Pietro Maggioni, Béla Merkely, Franz-Josef Neumann, Massimo F. Piepoli, Frans Van de Werf, Freek Verheugt, Lars Wallentin - European Heart Journal 2012 cited by 6,842

  11. Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial

    Authors: , , , , , , , , , , , , , - European Heart Journal 2016 cited by 327

  12. A Validated Prediction Model for All Forms of Acute Coronary Syndrome

    Authors: , , , , , , , , , , , , , , - JAMA 2004 cited by 1,589

  13. Extent, Location, and Clinical Significance of Non–Infarct-Related Coronary Artery Disease Among Patients With ST-Elevation Myocardial Infarction

    Authors: , , , , , , , , , , , , , - JAMA 2014 cited by 371

  14. Sudden Death in Patients with Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both

    Authors: , , , , , , , , , , , , , , - New England Journal of Medicine 2005 cited by 788

  15. Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial

    Authors: - The Lancet 1999 cited by 880

  16. Fibrinolysis or Primary PCI in ST-Segment Elevation Myocardial Infarction

    Authors: , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2013 cited by 783

  17. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Victora Delgado, Donna Fitzsimons, Oliver Gaemperli, Nazzareno Galiè, Martine Gilard, Christian W. Hamm, Borja Ibáñez, Bernard Iung, Stefan James, Juhani Knuuti, Ulf Landmesser, Christophe Leclercq, Maddalena Lettino, Gregory Y.H. Lip, Massimo Piepoli, Luc Piérard, Markus Schwerzmann, Udo Sechtem, Iain A. Simpson, Miguel Sousa‐Uva, Eugenio Stabile, Robert F. Storey, Michał Tendera, Frans Van de Werf, Freek W.A. Verheugt, Victor Aboyans - European Journal of Cardio-Thoracic Surgery 2017 cited by 412

  18. The need for transparency of clinical evidence for medical devices in Europe

    Authors: , , , , , , - The Lancet 2018 cited by 101

  19. Peripheral Blood RNA Levels of QSOX1 and PLBD1 Are New Independent Predictors of Left Ventricular Dysfunction After Acute Myocardial Infarction

    Authors: , , , , , , , , , , , , , - Circulation Genomic and Precision Medicine 2019 cited by 68

  20. STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment–Elevation Myocardial Infarction: A Randomized, Open-Label Trial

    Authors: , , , , , , , , , , , , , , , , , , , , - Circulation 2023 cited by 54

  21. Predictors of 30-Day Mortality in the Era of Reperfusion for Acute Myocardial Infarction

    Authors: , , , , , , , , , - Circulation 1995 cited by 1,093

  22. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials

    Authors: , , , , , , , , , , , , , - The Lancet 2002 cited by 1,004

  23. Acute Coronary Care in the Elderly, Part I

    Authors: , , , , , , , , , , , , - Circulation 2007 cited by 912

  24. Sex, Clinical Presentation, and Outcome in Patients with Acute Coronary Syndromes

    Authors: , , , , , , , , - New England Journal of Medicine 1999 cited by 903